Join
Live feed
·
INSIDERFilingvia Quantisnow
Krystal Biotech Inc. logo

President and CEO Krishnan Krish S covered exercise/tax liability with 30,584 shares and converted options into 67,225 shares, increasing direct ownership by 2% to 1,500,253 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KRYS (Krystal Biotech Inc.) and more on Quantisnow.